Asian Scientist Newsroom
ABOUT
Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.
Stories by Asian Scientist Newsroom
Oral Proteasome Inhibitor Could Improve Multiple Myeloma Treatment
Takeda has announced clinical study results combining oral investigational MLN9708 with lenalidomide and dexamethasone, in patients with newly diagnosed multiple myeloma.
Researchers Convert Human Embryonic Stem Cells Into Blastocyst-Like Cells
Scientists have converted human embryonic stem cells to a state that is closer to the cells found in the human blastocyst.
Worm-Like Nanoparticles More Deadly To Breast Cancer
Cylindrical shaped nanoparticles are seven times more deadly than traditional spherical ones when delivering drugs to breast cancer cells, according to a study.
Stomach ‘Clock’ Tells Us To Eat At Specific Times Of The Day
Researchers have discovered the first evidence that the nerves in the stomach act as a circadian clock, limiting food intake to specific times of the day.
Teva, Takeda To Commercialize Multiple Sclerosis Drug
Teva and Takeda will jointly commercialize Teva’s glatiramer acetate formulation for the treatment of multiple sclerosis in Japan.
Swiss Pharma Helsinn Group Opens Chinese Unit
Helsinn Group, a Swiss pharmaceutical company that focuses on oncologic products, has opened a representative office in Beijing, China.
JHL Biotech, Selexis SA Provide Speedy Drug Manufacturing Services
JHL Biotech and Selexis SA are collaborating to provide a seamless solution for the development and cGMP manufacturing of biologic drugs.
NovaBay, China Pioneer Pharma To Co-Market Products
NovaBay Pharma has partnered with China Pioneer Pharma to market its products in China and 11 countries in Southeast Asia.
C3a-Like Small Molecule To Replace Expensive Protein Therapeutics
Researchers in Australia have pioneered a drug development technique that could pave the way for a new class of low-cost medicines.